Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Public ClinicalTrials.gov record NCT05535166. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Study identification
- NCT ID
- NCT05535166
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Interventions
- Carboplatin Drug
- Cisplatin Drug
- Cyclophosphamide Drug
- Educational and Media Intervention Other
- Etoposide Drug
- Filgrastim Drug
- Irradiation Radiation
- Methotrexate Drug
- Ommaya/VPS Procedure
- Pegfilgrastim Drug
- SOC, Educational and Media Intervention Other
- Surgical resection Procedure
- Topotecan Drug
- Vincristine Drug
Drug · Other · Radiation + 1 more
Eligibility (public fields only)
- Age range
- Up to 59 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2022
- Primary completion
- Jun 30, 2035
- Completion
- Jun 30, 2035
- Last update posted
- Feb 11, 2026
2022 – 2035
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lucille Packard Children's Hospital Stanford | Palo Alto | California | 94304 | Recruiting |
| Orlando Health Arnold Palmer Hospital for Children | Orlando | Florida | 32806 | Recruiting |
| St. Joseph's Children's Hospital | Tampa | Florida | 33607 | Recruiting |
| C.S. MOTT Children's Hospital, University of Michigan | Ann Arbor | Michigan | 48109 | Recruiting |
| Children's Hospital and Clinics of Minnesota | Minneapolis | Minnesota | 55404 | Recruiting |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | Recruiting |
| UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center | Dallas | Texas | 75235 | Recruiting |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | Recruiting |
| Texas Children's Hospital | Houston | Texas | 77477 | Recruiting |
| Primary Children's Hospital | Salt Lake City | Utah | 84113 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05535166, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05535166 live on ClinicalTrials.gov.